Ethyl 5-methyl-1H-imidazole-4-carboxylate

Catalog No. :
ACMDXT670
CAS No. :
51605-32-4
Molecular Formula :
C7H10N2O2
Molecular Weight :
154.17

IUPAC Name:ethyl 5-methyl-1H-imidazole-4-carboxylate

Ethyl 5-methyl-1H-imidazole-4-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100g98%$88.00Login to see priceIn stockInquiry
500g98%$439.00Login to see priceIn stockInquiry
1000g98%$747.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 5-methyl-1H-imidazole-4-carboxylate
IUPAC Nameethyl 5-methyl-1H-imidazole-4-carboxylate
MDL No.MFCD00005199
Molecular FormulaC7H10N2O2
Molecular Weight154.17
SMILESO=C(C1=C(C)NC=N1)OCC
InChI KeyVLDUBDZWWNLZCU-UHFFFAOYSA-N
SynonymNSC 195976 | 4-methyl-5-carbethoxyimidazole | MFCD09749828 | AKOS015860168 | ethyl 4-methyl-1H-imidazole-5-carboxylate;Ethyl 5-methyl-1H-imidazole-4-carboxylate | ETHYL5-METHYL-1H-IMIDAZOLE-4-CARBOXYLATE | EINECS 257-315-3 | 5-methyl-1H-imidazole-4-carbox
CAS No.51605-32-4
PubChem CID99200

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACMDXT670 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. ACEATF219 route compound structure diagram
    ACEATF2191457-59-6 In Stock
  4. Then
  5. ACMDXT670 route product structure diagram
    ACMDXT67051605-32-4 In Stock
Inquiry

2. ACMDXT670 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEATF219 route compound structure diagram
    ACEATF2191457-59-6 In Stock
  4. Then
  5. ACMDXT670 route product structure diagram
    ACMDXT67051605-32-4 In Stock
Inquiry

Comments (0)